Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tatiana Tilli"'
Publikováno v:
PLoS ONE, Vol 10, Iss 1, p e0115054 (2015)
In this report, we describe a strategy for the optimized selection of protein targets suitable for drug development against neoplastic diseases taking the particular case of breast cancer as an example. We combined human interactome and transcriptome
Externí odkaz:
https://doaj.org/article/5670dfc7ae6f40df9ecd362b312010de
Publikováno v:
Annals of the symposium: vacines, biopharmaceuticals, in vitro diagnosis, management, other related themes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69775a39e734f137d8b75e82f77dcaf1
https://doi.org/10.35259/isi.2022_52254
https://doi.org/10.35259/isi.2022_52254
Publikováno v:
Annals of the symposium: vacines, biopharmaceuticals, in vitro diagnosis, management, other related themes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bbb2e70248705d1c78372b5f9451e9b
https://doi.org/10.35259/isi.2022_52186
https://doi.org/10.35259/isi.2022_52186
Autor:
Danielle de Brito e Cunha, Ana Frederico, Tamiris Azamor, Juliana Melgaço, Patricia da Costa Neves, Ana Bom, Tatiana Tilli, Sotiris Missailidis
Publikováno v:
Pharmaceuticals. 15:575
The depth and versatility of siRNA technologies enable their use in disease targets that are undruggable by small molecules or that seek to achieve a refined turn-off of the genes for any therapeutic area. Major extracellular barriers are enzymatic d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0095c0d8d4bbcfb4d3ea8c82997b7f2a
https://doi.org/10.3390/ph15050575
https://doi.org/10.3390/ph15050575
Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
Autor:
Tatiana Tilli
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 1348, p 1348 (2021)
Journal of Personalized Medicine, Vol 11, Iss 1348, p 1348 (2021)
Breast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c31a513d8a15865e17548fc6f3126c8
https://doi.org/10.3390/jpm11121348
https://doi.org/10.3390/jpm11121348
Publikováno v:
PLoS ONE, Vol 10, Iss 1, p e0115054 (2015)
PLoS ONE
PLoS ONE
In this report, we describe a strategy for the optimized selection of protein targets suitable for drug development against neoplastic diseases taking the particular case of breast cancer as an example. We combined human interactome and transcriptome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91ead490b14fa6e43d1280e2d2ee7d7a
http://europepmc.org/articles/PMC4308075?pdf=render
http://europepmc.org/articles/PMC4308075?pdf=render